Summary Cellular DNA was analysed by flow cytometry in fine needle aspirates (FNA) from both benign and malignant breast lesions in order to determine the feasibility of flow cytometric analysis. In 22 of 26 (84%) benign and 69 of 74 (93%) malignant aspirates, sufficient cells were present to produce good quality DNA histograms. DNA in all 22 benign lesions was diploid. In contrast, of the 69 cancers with sufficient cells for analysis, 40 The method of aspiration has been described previously (Zajicek, 1965) , but briefly aspirates were obtained using a 23 gauge needle attached to a 10ml syringe. The lesion was localised with the needle tip and negative pressure applied. Using a gentle pumping action, material was aspirated into the needle, the pressure was released, and the needle withdrawn.
Fine needle aspiration (FNA) cytology is a valuable technique by which to confirm the diagnosis of breast cancer (Dixon et al., 1984) . Microscopic identification of the morphological features of malignancy does, however, demand considerable skill from the pathologist. The recent development of flow cytometry provides both a rapid and objective method of analysing specific cellular structures, such as DNA, using specific fluorochromes. Such studies have shown an abnormal nuclear DNA content to be a useful marker of malignancy (Barlogie et al., 1983) -the incidence of DNA abnormality in breast cancer having been reported to be between 44 and 90% (Kute et al., 1981; Olszewski et al., 1981) . The DNA content of individual breast cancer cells may also be related to tumour behaviour, there being a number of reports showing improved survival associated with normal or near normal DNA content in colon (Wolley et al., 1982) , prostate (Fordham et al., 1986) , and breast (Auer et al., 1980; Baildam et al., 1987; Kallioniemi et al., 1987) . Such a rapid and precise method of measuring tumour cell DNA content may therefore be of both diagnostic and prognostic value.
Although fresh, frozen, and paraffin-embedded breast tumour tissue have all proved suitable for flow cytometric analysis, material obtained by fine needle aspiration of the breast has not yet been systematically studied. Since the role of FNA cytology in the diagnosis of breast cancer in this unit is established (Dixon et al., 1984) The method of aspiration has been described previously (Zajicek, 1965) , but briefly aspirates were obtained using a 23 gauge needle attached to a 10ml syringe. The lesion was localised with the needle tip and negative pressure applied. Using a gentle pumping action, material was aspirated into the needle, the pressure was released, and the needle withdrawn.
Material was expelled onto 4 dry glass slides and smears prepared: 2 were air dried for subsequent May Grunwald Giemsa staining, and 2 were fixed in alcohol for Papanicoulaou staining. All slides were examined by two pathologists and categorised as either malignant, suspicious, benign or acellular (Dixon et al., 1984) . A further drop of aspirated material was taken for immunohistochemical assay of the oestrogen receptor. The remainder of the aspirate, which was to be used for flow cytometric analysis, was expelled into 200Il of citrated buffer, rapidly frozen on dry ice, and stored at -40°C until analysed (Vindel0v et al., 1983a) .
Flow cytometric DNA analysis Frozen whole cell suspensions were thawed in a water bath at 370C before preparing and staining the nuclei as described by Vindel0v et al. (1983b) with minor modifications.
Cell suspensions (100ll) were digested by mixing with trypsin (0.003%, 450,u1) and leaving at room temperature for 10 mins. Trypsin inhibitor (0.05% w/v) and RNAse (0.01%w/v) in a final volume of 375,p1 were then added and then left for a further 10mins. Finally, the cells were stained, on ice, with propidium iodide (416pgml-1) and spermine tetrahydrochloride (1.16mgml-1) in a final volume of 250p1. Samples were passed through a gauge 23 needle prior to analysis. by counting at least 10,000 sample nuclei at a speed of <50sec-.
Results
Of the 100 samples studied, 22 (Auer et al., 1980; Baildam et al., 1987; Kallioniemi et al., 1987) . Others indicate that ploidy per se is unlikely to be of prognostic value (Dowle et al., 1987; Owainati et al., 1987) , or is only an independent prognostic variable in postmenopausal patients (Cornelisse et al., 1987) .
To date, most flow cytometric DNA analysis has been carried out using excised tumour material. This present study therefore represents the first report on the use of cellular preparations from routine diagnostic breast tumour FNA's for flow cytometric analysis.
The results indicate that, in over 90% of malignant tumours and 80% of benign lesions, fine needle aspirates contain sufficient cells to provide, in addition to diagnostic cytopathology, good quality flow cytometric DNA histograms. Furthermore, the majority of samples contained minimal amounts of debris material, allowing the identification of any small sub-populations of cells.
All aspirates from tumours subsequently shown by routine pathology to be benign contained a single population of GO/GI cells, as did 40% of tumours confirmed as malignant; the remaining 60% of FNAs from cancers contained at least one DNA aneuploid line. These results would fall midway within the, albeit large, range of values reported by others (Kute et al., 1981; Olszewski et al., 1981) (Dixon et al., 1984) , it is more widely employed for routine diagnosis. In certain cases, flow cytometric DNA analysis of FNA material may provide additional diagnostic information in that although DNA aneuploid cells have been detected in benign lesions of the breast (Cornelisse et al., 1983; Uccelli et al., 1986 ) and other tissues (Danova et al., 1987; Jarvis et al., 1987; Joensuu et al., 1986) , the incidence is relatively low. The presence of a distinct population of DNA aneuploid cells may therefore be indicitive of malignancy. The presence of diploid cells alone can not however facilitate diagnosis, as these may be both non-malignant and malignant; although with the development of specific tumour markers it may subsequently be possible to distinguish between these diploid cell populations.
Whilst the results obtained from FNAs are compatible with those obtained from more conventional analysis of excised tumour tissue, the combination of flow cytometry and FNA cytology has more extensive applications. Thus, although not all patients are suitable for tumour biopsy, FNA cytology can be performed in most cases. For example, surgery may not be appropriate in the older patient, although information on cellular characteristics of the tumour might provide useful information on the nature of systemic therapy to be employed. Similarly, it would be possible to obtain an FNA on small or surgically inoperable metastatic lesions and again analysis could yield information useful to the management of the patient.
The simplicity and relatively non-invasiveness of FNA cytology not only permits the study of individual tumour cells prior to treatment, but also sequential sampling during therapy. Flow cytometric analysis may therefore allow direct monitoring of cellular changes occurring within a tumour during treatment, and we are currently exploring this approach in the management of large but operable breast tumours treated with initial systemic therapy (Forrest et al., 1986) . The ability to assess early response may allow appropriate drugs to be instituted sooner, and inappropriate ones to be promptly discontinued. In view of the toxicity of some chemotherapeutic agents, the latter may be particularly important.
To conclude, in the hands of an experienced aspirator, cellular material from FNAs of breast tumours provide suitable material for flow cytometric analysis. The combination of these techniques has great potential in terms of characterising the cellular properties of tumours without the need for surgical removal of tissue.
